WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 47'1101 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 38'2511 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 5'426  5'408  5'389  5'368  5'344  5'176  4'987  4'779 
Births 61  61  61  60  60  57  64  65 
Surviving infants 61  61  60  60  60  57  63  64 
Pop. less than 5 years 306  306  304  300  297  294  311  320 
Pop. less than 15 years 892  890  888  886  890  940  963  971 
Female 15-49 years 1'154  1'160  1'165  1'170  1'172  1'218  1'258  1'219 

Number of reported case

(Click for retrospective incidence data for Finland)
Diphtheria
Japanese encephalitis
Measles 27  2'147 
Mumps
Pertussis 192  555  336  267  707  187 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Finland)
Vaccine year result method % card seen                                                
BCG          99  99  91 
DTP1          99 
DTP3          98  99  99  99  99  90 
HepB_BD         
HepB3         
Hib3          98  99  99  99 
JapEnc         
MCV          97  97  97  99  96  97 
MCV2         
PCV1         
PCV3         
Pol3          98  99  99  99  95  90 
Rota1          94 
Rota_last          93 
Rubella1          97  97  97  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Finland)
BCG 99  91  90 
DTP1 99  99  99  99  99  99  96  97 
DTP3 98  99  99  99  99  99  90  92 
HepB3
HepB_BD
Hib3 98  99  99  99  98  96 
MCV 97  97  97  98  98  96  97 
MCV2
PnC3
Pol3 98  99  99  99  99  96  90  90 
Rota_last 93  93  93  93 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG < 7 years; Yes children at risk
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 4 years; Yes
HIB Separate Hib-vaccine only for children under 5 yrs of age to complete the vaccinations if children has been given 3 doses of DTP
HepA Yes Only for special risk groups
HepAHepB Yes Only for special risk groups
HepB Yes Only for special rsik groups, for children under 16, half of adults dose
IPV Yes Separate IPV-vaccine only for those whose vaccinations against polio is inadequate and for those travelling to endemic area if previous dose has been given over 5Y ago
Influenza 6-35 months; >=65 years; Yes and other special groups
MMR 12-18 months; 6 years; Yes
Pneumo_conj 3, 5, 12 months; Yes
Pneumo_ps <5 years; Yes risk group
Rotavirus 2, 3, 5 months; Yes
TBE >3 years; No Åland island
Td Yes every 10 years
Tdap 14-15 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number        

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number         NA  NA  NA 
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.